SpringWorks Therapeutics (SWTX) News Today $37.44 -0.49 (-1.29%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period SpringWorks Therapeutics (NASDAQ:SWTX) Now Covered by Evercore ISIEvercore ISI began coverage on shares of SpringWorks Therapeutics in a research note on Wednesday. They issued an "outperform" rating and a $60.00 price objective on the stock.November 20 at 8:38 AM | marketbeat.comSpringWorks Therapeutics (NASDAQ:SWTX) Earns Outperform Rating from WedbushNovember 20 at 2:40 AM | americanbankingnews.comVictory Capital Management Inc. Has $20.17 Million Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Victory Capital Management Inc. lifted its holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 19.7% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 629,387 shares of the company's stock aftNovember 19 at 3:57 AM | marketbeat.comWhat is HC Wainwright's Estimate for SWTX FY2024 Earnings?November 17, 2024 | americanbankingnews.comHC Wainwright Has Pessimistic View of SWTX FY2024 EarningsSpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) - Research analysts at HC Wainwright cut their FY2024 earnings estimates for shares of SpringWorks Therapeutics in a note issued to investors on Tuesday, November 12th. HC Wainwright analyst R. Burns now expects that the company will earnNovember 15, 2024 | marketbeat.comWedbush Equities Analysts Lower Earnings Estimates for SWTXSpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) - Investment analysts at Wedbush reduced their FY2024 earnings estimates for SpringWorks Therapeutics in a research report issued to clients and investors on Tuesday, November 12th. Wedbush analyst D. Nierengarten now expects that the comNovember 15, 2024 | marketbeat.comSOPHiA GENETICS (NASDAQ:SOPH) & SpringWorks Therapeutics (NASDAQ:SWTX) Head-To-Head ReviewNovember 15, 2024 | americanbankingnews.comLos Angeles Capital Management LLC Acquires 33,255 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Los Angeles Capital Management LLC lifted its holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 238.3% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 47,212 shares of the company'November 14, 2024 | marketbeat.comHC Wainwright Cuts SpringWorks Therapeutics (NASDAQ:SWTX) Price Target to $74.00November 14, 2024 | americanbankingnews.comSpringWorks Therapeutics (NASDAQ:SWTX) Shares Gap Down Following Analyst DowngradeNovember 14, 2024 | americanbankingnews.comBuy Rating Reaffirmed for Springworks Therapeutics Amid Promising Outlook for Ogsiveo and MirdametinibNovember 13, 2024 | markets.businessinsider.comBarclays Sticks to Its Buy Rating for Springworks Therapeutics (SWTX)November 13, 2024 | markets.businessinsider.comSpringWorks Therapeutics (NASDAQ:SWTX) Announces Earnings Results, Beats Estimates By $0.04 EPSSpringWorks Therapeutics (NASDAQ:SWTX - Get Free Report) released its quarterly earnings results on Tuesday. The company reported ($0.72) earnings per share for the quarter, topping the consensus estimate of ($0.76) by $0.04. The company had revenue of $49.10 million for the quarter, compared to analyst estimates of $53.28 million. During the same quarter last year, the company earned ($1.27) EPS. The firm's revenue for the quarter was up 4810.0% on a year-over-year basis.November 13, 2024 | marketbeat.comSpringWorks Therapeutics, Inc.: SpringWorks Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business HighlightsNovember 13, 2024 | finanznachrichten.deSpringWorks Therapeutics Q3 2024 Results OverviewNovember 13, 2024 | markets.businessinsider.comPrincipal Financial Group Inc. Acquires 464,903 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Principal Financial Group Inc. grew its stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 102.5% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 918,445 shares of the company's stock afteNovember 13, 2024 | marketbeat.comSpringWorks Therapeutics, Inc. (SWTX) Q3 2024 Earnings Call TranscriptNovember 12, 2024 | seekingalpha.comHC Wainwright Issues Pessimistic Forecast for SpringWorks Therapeutics (NASDAQ:SWTX) Stock PriceHC Wainwright lowered their price objective on shares of SpringWorks Therapeutics from $76.00 to $74.00 and set a "buy" rating for the company in a research report on Tuesday.November 12, 2024 | marketbeat.comSpringWorks Therapeutics to Participate in the Jefferies London Healthcare ConferenceNovember 12, 2024 | globenewswire.comSpringWorks Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business HighlightsNovember 12, 2024 | globenewswire.comEarnings To Watch: SpringWorks Therapeutics Inc (SWTX) Reports Q3 2024 ResultNovember 11, 2024 | finance.yahoo.comSpringWorks Therapeutics Announces Mirdametinib Data to be Presented at the 2024 Society for Neuro-Oncology (SNO) Annual MeetingNovember 11, 2024 | globenewswire.comSpringWorks Therapeutics Announces Publication of the Pivotal Phase 2b ReNeu Trial Evaluating Mirdametinib in Adults and Children with NF1-PN in the Journal of Clinical OncologyNovember 11, 2024 | globenewswire.comSpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Given Consensus Recommendation of "Buy" by BrokeragesNovember 11, 2024 | americanbankingnews.comFiera Capital Corp Sells 39,338 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Fiera Capital Corp trimmed its position in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 3.0% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,257,964 shares of the company's stockNovember 9, 2024 | marketbeat.comSpringWorks Therapeutics Announces Long-Term Efficacy and Safety Data from Phase 3 DeFi Trial of OGSIVEO® (nirogacestat) in Adults with Desmoid Tumors to be Presented at the Connective Tissue Oncology Society (CTOS) 2024 Annual MeetingNovember 7, 2024 | globenewswire.comSpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Receives Average Rating of "Buy" from AnalystsShares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Get Free Report) have earned an average recommendation of "Buy" from the six analysts that are currently covering the company, MarketBeat reports. Six equities research analysts have rated the stock with a buy rating. The average 12-month tarNovember 6, 2024 | marketbeat.comSpringWorks Therapeutics to Participate in Guggenheim’s Inaugural Healthcare Innovation ConferenceNovember 5, 2024 | finance.yahoo.comSpringWorks Therapeutics (SWTX) Scheduled to Post Earnings on TuesdaySpringWorks Therapeutics (NASDAQ:SWTX) will be releasing earnings before the market opens on Tuesday, November 12, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=638250)November 5, 2024 | marketbeat.comSpringWorks Therapeutics to Participate in Guggenheim's Inaugural Healthcare Innovation ConferenceNovember 5, 2024 | globenewswire.comSpringWorks Therapeutics (NASDAQ:SWTX) Is In A Good Position To Deliver On Growth PlansNovember 4, 2024 | finance.yahoo.comTD Cowen Remains a Buy on Springworks Therapeutics (SWTX)October 22, 2024 | markets.businessinsider.comSpringWorks Therapeutics to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024October 22, 2024 | globenewswire.comSpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Receives Average Recommendation of "Buy" from BrokeragesSpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Get Free Report) has been given an average rating of "Buy" by the six research firms that are presently covering the company, MarketBeat Ratings reports. Six equities research analysts have rated the stock with a buy rating. The average twelve-month prOctober 12, 2024 | marketbeat.comAQR Capital Management LLC Has $1.41 Million Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)AQR Capital Management LLC raised its stake in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 92.9% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 37,413 shares of the company's stock after acquiring an additionalOctober 11, 2024 | marketbeat.comSpringWorks Therapeutics Inc (SWTX) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and ...October 9, 2024 | finance.yahoo.comSpringWorks Therapeutics (NASDAQ:SWTX) Shares Down 4.5% - Should You Sell?SpringWorks Therapeutics (NASDAQ:SWTX) Trading Down 4.5% - Should You Sell?October 9, 2024 | marketbeat.comThe Manufacturers Life Insurance Company Sells 21,611 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)The Manufacturers Life Insurance Company decreased its holdings in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 14.9% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 123,418 shOctober 8, 2024 | marketbeat.comDimensional Fund Advisors LP Lowers Stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Dimensional Fund Advisors LP reduced its position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 8.3% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 830,522 shares of the company'October 2, 2024 | marketbeat.comPerceptive Advisors LLC Sells 609,500 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Perceptive Advisors LLC trimmed its stake in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 26.9% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,652,962 shares of the company's stock afSeptember 30, 2024 | marketbeat.comD. E. Shaw & Co. Inc. Boosts Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)D. E. Shaw & Co. Inc. grew its stake in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 16.9% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 758,712 shares of the company's stock aSeptember 29, 2024 | marketbeat.comMaverick Capital Ltd. Grows Stock Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Maverick Capital Ltd. boosted its stake in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 36.3% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,600,524 shares of the company's stock after buySeptember 27, 2024 | marketbeat.comDuquesne Family Office LLC Invests $38.48 Million in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Duquesne Family Office LLC acquired a new stake in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 1,021,367 shares of the company's stocSeptember 26, 2024 | marketbeat.comAffinity Asset Advisors LLC Has $2.64 Million Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Affinity Asset Advisors LLC cut its holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 30.0% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 69,999 shares of the company's stock after selling 30,001 shares during the quarter. AffinitySeptember 25, 2024 | marketbeat.comXTX Topco Ltd Invests $621,000 in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)XTX Topco Ltd purchased a new position in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 16,491 shares of the company's stock, valueSeptember 24, 2024 | marketbeat.comSpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Shares Acquired by Mutual of America Capital Management LLCMutual of America Capital Management LLC lifted its position in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 41.4% during the 2nd quarter, according to its most recent disclosure with the SEC. The firm owned 116,915 shares of the company's stock after buying an additionalSeptember 22, 2024 | marketbeat.comMassachusetts Financial Services Co. MA Purchases 69,227 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Massachusetts Financial Services Co. MA raised its position in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 14.9% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 535,083 shSeptember 21, 2024 | marketbeat.comEven though SpringWorks Therapeutics (NASDAQ:SWTX) has lost US$229m market cap in last 7 days, shareholders are still up 49% over 5 yearsSeptember 19, 2024 | finance.yahoo.comSeven Eight Capital LP Takes Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Seven Eight Capital LP bought a new position in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund bought 49,224 shares of the company's stock, valued at approximately $1,854,000. SevenSeptember 19, 2024 | marketbeat.comVictory Capital Management Inc. Raises Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Victory Capital Management Inc. boosted its holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 3.7% in the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 525,983 shares of the company's stock after purchasing an additional 18,652 shaSeptember 13, 2024 | marketbeat.com Get SpringWorks Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SWTX and its competitors with MarketBeat's FREE daily newsletter. Email Address [625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad)All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen. Register for the FREE Workshop Now & get $10 in Bitcoin SWTX Media Mentions By Week SWTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SWTX News Sentiment▼0.180.46▲Average Medical News Sentiment SWTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SWTX Articles This Week▼154▲SWTX Articles Average Week Get SpringWorks Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SWTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Beam Therapeutics News Today Vir Biotechnology News Today Replimune Group News Today Allogene Therapeutics News Today AlloVir News Today bluebird bio News Today Exelixis News Today Vaxcyte News Today Catalent News Today Sarepta Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SWTX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SpringWorks Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SpringWorks Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
